1. Study on the correlation between meteorological factors and acute otitis media in outpatients of children in Beijing
Yingxia LU ; Jieqiong LIANG ; Qinglong GU ; Xuemei YU ; Xue YAN
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2017;52(10):724-728
Objective:
To explore the characteristics of acute otitis media(AOM) in children in Beijing and its correlation with meteorological factors.
Methods:
Data were collected in 2011-2013 in the Otolaryngology Department of Capital Institute of Pediatrics. AOM in children with relevant information, such as age, sex and season, with the same period of the Beijing municipal meteorological data (the average temperature, average pressure, average wind speed, humidity and PM2.5) were compared to analysis the relationship of meteorological environmental parameters and the onset of AOM in children.
Results:
Annual morbidity of AOM was 7 589, 8 245, 7 242 respectively, no obvious difference(
2.Preparation and performance evaluation of controlled-release chitosan-based microneedles.
Long ZHU ; Jian ZHUANG ; Zewei ZHAO ; Fengyi LIU ; Qinglong XUE ; Jingyao SUN ; Yao HUANG ; Hong XU
Chinese Journal of Biotechnology 2022;38(9):3478-3488
In clinical application, a microneedle system that continuously delivers drugs is of great value for the delivery of some vaccines and hormone drugs. In this study, a controlled-release chitosan-based microneedle array (PVA/CS-MN) was designed, combining microneedle patches with drugs for controlled-release of drugs. Here we report the optimization of the preparation process of PVA/CS-MN. The appearance, morphology, mechanical properties, dissolution and swelling properties, and in vitro penetration properties of the MN arrays were characterized. The PVA/CS-MN prepared by the optimal process showed good morphology and mechanical properties. PVA/CS-MN can smoothly open microchannels on the skin and achieve controllable dissolution and swelling functions. Ascorbic acid (l-ascorbic acid) was used as a model drug to prepare a Vc-PVA/CS-MN. In vitro transdermal diffusion experiments showed that the Vc-PVA/CS-MN released about 57% of the drug within 1 h. About 66.7% of the drug was slowly released within 12 h, and a total of 92% of the drug was released after 7 days. The controllable sustained-release properties and excellent drug delivery efficiency of PVA/CS-MN provide a new option for sustained transdermal drug delivery.
Ascorbic Acid
;
Chitosan
;
Delayed-Action Preparations
;
Drug Delivery Systems
;
Hormones
;
Vaccines